Company and People Notes: Chesapeake to Relocate and Expand, AVI BioPharma Appoints CEO, More

The two companies will be exhibiting together after Gerresheimer’s December 2024 acquisition of Bormioli.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

This investment is additional to and separate from £11 million that was announced in the fall of 2024 for creating new jobs and expanding Almac’s global analytical services capabilities.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

The collaboration will leverage Thermo Fisher’s Accelerator Drug Development stable of solutions, which was launched in the fall of 2024.

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.